HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Blistex requests lip care category exemption from FDA's proposed OTC labeling reg.

This article was originally published in The Rose Sheet

Executive Summary

OTC LABEL REG EXEMPTION FOR LIP PRODUCTS SOUGHT BY BLISTEX because "these products, whether sold in cartons or sold uncartoned...are too small to comply with the formatting requirements," the lip care company maintains in Oct. 6 comments on FDA's proposed over-the-counter drug label reform initiative. Therefore, Blistex requests that "the agency provide...a regulation exempting lip care products." Prepared by the Washington, D.C.-based law firm Hyman, Phelps & McNamara, Blistex' comments petition for a specific product category exemption that would include medicated lip balms in pot and stick form and lipsticks with sunscreens.
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS004744

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel